-
Mashup Score: 0Daily tiotropium improves lung function, but not exacerbation frequency in bronchiectasis - 2 year(s) ago
Daily tiotropium via the HandiHaler device improved lung function but did not reduce frequency of exacerbations over 6 months in patients with stable bronchiectasis, according to results published in European Respiratory Journal.“In clinical practice, tiotropium bromide via the HandiHaler device has been prescribed for [more than] 15 years for patients with COPD, for whom it is has been
Source: www.healio.comCategories: Latest Headlines, PulmonologyTweet
-
Mashup Score: 0Daily tiotropium improves lung function, but not exacerbation frequency in bronchiectasis - 2 year(s) ago
Daily tiotropium via the HandiHaler device improved lung function but did not reduce frequency of exacerbations over 6 months in patients with stable bronchiectasis, according to results published in European Respiratory Journal.“In clinical practice, tiotropium bromide via the HandiHaler device has been prescribed for [more than] 15 years for patients with COPD, for whom it is has been
Source: www.healio.comCategories: General Medicine News, Latest HeadlinesTweet-
Tiotropium significantly improved #lungfunction in patients with stable #bronchiectasis, but did not reduce exacerbation frequency, according to results of a randomized, placebo-controlled trial @ERSpublications https://t.co/ttPQPV89sO
-
-
Mashup Score: 0One-third of patients with rheumatoid arthritis-associated ILD experience acute exacerbation - 2 year(s) ago
The incidence of acute exacerbation was nearly one-third in patients with rheumatoid arthritis-associated interstitial lung disease, researchers reported in Chest.Ever smoking, lower lung function and exercise capacity were identified as risk factors for acute exacerbation in this patient population.
Source: www.healio.comCategories: General Medicine News, Latest HeadlinesTweet-
Approximately one-third of patients with #RAILD experience acute exacerbations, with ever #smoking, lower #lungfunction and #exercise capacity identified as risk factors, according to a new study in @Journal_CHEST @HealioRheum https://t.co/p1qJoa4MJr
-
Approximately one-third of patients with #RAILD experience acute exacerbations, with ever #smoking, lower #lungfunction and #exercise capacity identified as risk factors, according to a new study in @Journal_CHEST @HealioRheum https://t.co/TWaaPpncUW
-
-
Mashup Score: 0
Children with increased exposure to nature during childhood had improved lung function in later life, according to study findings published in European Respiratory Journal.“We found that living in greener neighborhoods as children grow up is more important for their breathing than living in a green area when they were born,” Diogo Queiroz Almeida, MD, PhD candidate in the department
Source: www.healio.comCategories: Latest Headlines, PulmonologyTweet-
Children with increased exposure to nature during their childhood had improved #lungfunction, according to results published in @ERSpublications https://t.co/BmcUq5SlJv
-
-
Mashup Score: 0
Children with increased exposure to nature during childhood had improved lung function in later life, according to study findings published in European Respiratory Journal.“We found that living in greener neighborhoods as children grow up is more important for their breathing than living in a green area when they were born,” Diogo Queiroz Almeida, MD, PhD candidate in the department
Source: www.healio.comCategories: General Medicine News, Latest HeadlinesTweet-
Children with increased exposure to nature during their childhood had improved #lungfunction, according to results published in @ERSpublications https://t.co/WeokE9zHCk
-
Children with increased exposure to nature during their childhood had improved #lungfunction, according to results published in @ERSpublications https://t.co/u0iVmtEd7a
-
-
Mashup Score: 0New clinical trial to evaluate dupilumab in children with asthma living in urban areas - 2 year(s) ago
The NIH launched a clinical trial to assess whether dupilumab can reduce asthma exacerbations and improve lung function and symptoms in children with poorly controlled allergic asthma in low-income urban areas.Currently, dupilumab (Regeneron/Sanofi) is approved by the FDA as an add-on maintenance treatment for certain moderate to severe asthma types in individuals aged 6 years and older.
Source: www.healio.comCategories: Latest Headlines, PulmonologyTweet-
A new clinical trial launched by the NIH will evaluate whether #dupilumab reduces #asthma exacerbations and improves #lungfunction and asthma symptoms in children with poorly controlled asthma. @HealioAllergy https://t.co/U2Hyk5iuIw
-
-
Mashup Score: 1New clinical trial to evaluate dupilumab in children with asthma living in urban areas - 2 year(s) ago
The NIH launched a clinical trial to assess whether dupilumab can reduce asthma exacerbations and improve lung function and symptoms in children with poorly controlled allergic asthma in low-income urban areas.Currently, dupilumab (Regeneron/Sanofi) is approved by the FDA as an add-on maintenance treatment for certain moderate to severe asthma types in individuals aged 6 years and older.
Source: www.healio.comCategories: General Medicine News, Latest HeadlinesTweet-
A new clinical trial launched by the NIH will evaluate whether #dupilumab reduces #asthma exacerbations and improves #lungfunction and asthma symptoms in children with poorly controlled asthma. @HealioAllergy https://t.co/jP3IieIpxa
-
A new clinical trial launched by the NIH will evaluate whether #dupilumab reduces #asthma exacerbations and improves #lungfunction and asthma symptoms in children with poorly controlled asthma. @HealioAllergy https://t.co/lU4wKnWJuI
-
-
Mashup Score: 0
Lung function in extremely preterm infants fell significantly below trajectories of term-born children in early adult life, researchers reported in BMJ Thorax.“This is the first longitudinal study to describe lung function trajectories from childhood and well into adulthood for population-based cohorts of extremely preterm-born survivors,” Tonje Bårdsen, MD, from the department of
Source: www.healio.comCategories: Latest Headlines, PulmonologyTweet-
Compared with term-born infants, #lungfunction of extremely preterm infants was significantly lower in early adulthood and throughout the onset of age-related decline @BMJ_Latest @ThoraxBMJ https://t.co/PhFhmRfWxO
-
-
Mashup Score: 0
Lung function in extremely preterm infants fell significantly below trajectories of term-born children in early adult life, researchers reported in BMJ Thorax.“This is the first longitudinal study to describe lung function trajectories from childhood and well into adulthood for population-based cohorts of extremely preterm-born survivors,” Tonje Bårdsen, MD, from the department of
Source: www.healio.comCategories: Latest Headlines, PulmonologyTweet-
#ICYMI: Researchers found significantly lower #lungfunction among extremely preterm infants in early adulthood and throughout the onset of age-related decline compared with term-born infants. @BMJ_Latest @ThoraxBMJ https://t.co/PhFhmRfWxO
-
-
Mashup Score: 0
Lung function in extremely preterm infants fell significantly below trajectories of term-born children in early adult life, researchers reported in BMJ Thorax.“This is the first longitudinal study to describe lung function trajectories from childhood and well into adulthood for population-based cohorts of extremely preterm-born survivors,” Tonje Bårdsen, MD, from the department of
Source: www.healio.comCategories: General Medicine News, Latest HeadlinesTweet-
Compared with term-born infants, #lungfunction of extremely preterm infants was significantly lower in early adulthood and throughout the onset of age-related decline @BMJ_Latest @ThoraxBMJ https://t.co/RhkrJerapa
-
Compared with term-born infants, #lungfunction of extremely preterm infants was significantly lower in early adulthood and throughout the onset of age-related decline @BMJ_Latest @ThoraxBMJ https://t.co/GFQc9VmTql
-
Tiotropium significantly improved #lungfunction in patients with stable #bronchiectasis, but did not reduce exacerbation frequency, according to results of a randomized, placebo-controlled trial @ERSpublications https://t.co/hq8SO45RfJ